Company Overview of Sucampo Pharmaceuticals, Inc.
Peter S. Greenleaf
Chairman & CEO, Sucampo Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 4 Board Members in 4 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2016
805 King Farm BoulevardPhone: 301-961-3400
Rockville, Maryland 20850
Board Members Memberships
Chairman & CEO
Saint Joseph's University
Western Connecticut State University
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Mark R. Baker J.D.||Chief Executive Officer and Director|
Progenics Pharmaceuticals, Inc.
|Gary S. Jacob Ph.D.||Chairman of the Board, CEO & President|
Synergy Pharmaceuticals Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals, Inc.
|A. J. Kazimi MBA||Founder, Chairman, Chief Executive Officer and President|
Cumberland Pharmaceuticals Inc.
|John Anthony Sedor||Chairman and Chief Executive Officer|
Pernix Therapeutics Holdings, Inc.
|$805.7K||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.